Aardvark Therapeutics Inc (AARD) PT Lowered to $21 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tim Anderson lowered the price target on Aardvark Therapeutics Inc (NASDAQ: AARD) to $21.00 (from $25.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
